Literature DB >> 29920066

High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics.

Xian Luo1, Mingrui An2, Kyle C Cuneo2, David M Lubman2, Liang Li1.   

Abstract

Circulating exosomes in bodily fluids such as blood are being actively studied as a rich source of chemical biomarkers for cancer diagnosis and monitoring. Although nucleic acid analysis is a primary tool for the discovery of circulating biomarkers in exosomes, metabolomics holds the potential of expanding the chemical diversity of biomarkers that may be easy and rapid to detect. However, only trace amounts of exosomes can be isolated from a small volume of patient blood, and thus a very sensitive technique is required to analyze the metabolome of exosomes. In this report, we present a workflow that involves multiple cycles of ultracentrifugation for exosome isolation using a starting material of 2 mL of human serum, freeze-thaw-cycles in 50% methanol/water for exosome lysis and metabolite extraction, differential chemical isotope labeling (CIL) of metabolites for enhancing liquid chromatography (LC) separation and improving mass spectrometry (MS) detection, and nanoflow LC-MS (nLC-MS) with captivespray for analysis. As a proof-of-principle, we used dansylation labeling to analyze the amine- and phenol-submetabolomes in two sets of exosome samples isolated from the blood samples of five pancreatic cancer patients before and after chemotherapy treatment. The average number of peak pairs or metabolites detected was 1964 ± 60 per sample for a total of 2446 peak pairs ( n = 10) in the first set and 1948 ± 117 per sample for a total of 2511 peak pairs ( n = 10) in the second set. There were 101 and 94 metabolites positively identified in the first and second set, respectively, and 1580 and 1590 peak pairs with accurate masses matching those of metabolites in the MyCompoundID metabolome database. Analyzing the mixtures of 12C-labeled individual exosome samples spiked with a 13C-labeled pooled sample which served as an internal standard allowed relative quantification of metabolomic changes of exosomes of blood samples collected before and after treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29920066      PMCID: PMC6058730          DOI: 10.1021/acs.analchem.8b01726

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  39 in total

Review 1.  Exosomes: proteomic insights and diagnostic potential.

Authors:  Richard J Simpson; Justin We Lim; Robert L Moritz; Suresh Mathivanan
Journal:  Expert Rev Proteomics       Date:  2009-06       Impact factor: 3.940

2.  Development of isotope labeling liquid chromatography-mass spectrometry for metabolic profiling of bacterial cells and its application for bacterial differentiation.

Authors:  Yiman Wu; Liang Li
Journal:  Anal Chem       Date:  2013-03-29       Impact factor: 6.986

Review 3.  Lipids in exosomes: Current knowledge and the way forward.

Authors:  Tore Skotland; Kirsten Sandvig; Alicia Llorente
Journal:  Prog Lipid Res       Date:  2017-03-23       Impact factor: 16.195

Review 4.  Tumor-Derived Exosomes and Their Role in Cancer Progression.

Authors:  Theresa L Whiteside
Journal:  Adv Clin Chem       Date:  2016-04-07       Impact factor: 5.394

Review 5.  Shedding light on the cell biology of extracellular vesicles.

Authors:  Guillaume van Niel; Gisela D'Angelo; Graça Raposo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-17       Impact factor: 94.444

6.  Exosome enrichment of human serum using multiple cycles of centrifugation.

Authors:  Jeongkwon Kim; Zhijing Tan; David M Lubman
Journal:  Electrophoresis       Date:  2015-07-15       Impact factor: 3.535

7.  In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

Authors:  Simona Principe; E Ellen Jones; Yunee Kim; Ankit Sinha; Julius O Nyalwidhe; Jasmin Brooks; O John Semmes; Dean A Troyer; Raymond S Lance; Thomas Kislinger; Richard R Drake
Journal:  Proteomics       Date:  2013-04-23       Impact factor: 3.984

Review 8.  Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives.

Authors:  Simona Fontana; Fontana Simona; Laura Saieva; Saieva Laura; Simona Taverna; Taverna Simona; Riccardo Alessandro; Alessandro Riccardo
Journal:  Proteomics       Date:  2013-03-22       Impact factor: 3.984

9.  High-Performance Chemical Isotope Labeling Liquid Chromatography-Mass Spectrometry for Profiling the Metabolomic Reprogramming Elicited by Ammonium Limitation in Yeast.

Authors:  Xian Luo; Shuang Zhao; Tao Huan; Difei Sun; R Magnus N Friis; Michael C Schultz; Liang Li
Journal:  J Proteome Res       Date:  2016-03-29       Impact factor: 4.466

10.  Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.

Authors:  Maija Puhka; Maarit Takatalo; Maria-Elisa Nordberg; Sami Valkonen; Jatin Nandania; Maria Aatonen; Marjo Yliperttula; Saara Laitinen; Vidya Velagapudi; Tuomas Mirtti; Olli Kallioniemi; Antti Rannikko; Pia R-M Siljander; Taija Maria Af Hällström
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

View more
  21 in total

1.  Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.

Authors:  Lianyuan Tao; Juntuo Zhou; Chunhui Yuan; Lingfu Zhang; Deyu Li; Dandan Si; Dianrong Xiu; Lijun Zhong
Journal:  Metabolomics       Date:  2019-05-30       Impact factor: 4.290

2.  Extracellular Vesicles in Metabolism and Metabolic Diseases.

Authors:  Akbar L Marzan; Christina Nedeva; Suresh Mathivanan
Journal:  Subcell Biochem       Date:  2021

Review 3.  Biosensor-based assay of exosome biomarker for early diagnosis of cancer.

Authors:  Ying Deng; Zhaowei Sun; Lei Wang; Minghui Wang; Jie Yang; Genxi Li
Journal:  Front Med       Date:  2021-09-27       Impact factor: 4.592

Review 4.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 5.  David M. Lubman-The University of Michigan-A retrospective in research.

Authors:  David M Lubman
Journal:  Mass Spectrom Rev       Date:  2021-07-21       Impact factor: 10.946

Review 6.  Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment.

Authors:  Katarzyna Nazimek; Krzysztof Bryniarski
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

Review 7.  Noninvasive Assessment of Exosome Pharmacokinetics In Vivo: A Review.

Authors:  Do Hee Kim; Vinoth Kumar Kothandan; Hye Won Kim; Ki Seung Kim; Ji Young Kim; Hyeon Jin Cho; Yong-Kyu Lee; Dong-Eun Lee; Seung Rim Hwang
Journal:  Pharmaceutics       Date:  2019-12-03       Impact factor: 6.321

8.  Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.

Authors:  Jessica I Sanchez; Jingjing Jiao; Suet-Ying Kwan; Lucas Veillon; Marc O Warmoes; Lin Tan; Mobolaji Odewole; Nicole E Rich; Peng Wei; Philip L Lorenzi; Amit G Singal; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-12

Review 9.  Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses.

Authors:  Fanny A Pelissier Vatter; Michele Cioffi; Samer J Hanna; Ines Castarede; Simone Caielli; Virginia Pascual; Irina Matei; David Lyden
Journal:  J Exp Med       Date:  2021-06-28       Impact factor: 14.307

10.  Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future Perspectives.

Authors:  J Spencer Lane; Daniel Von Hoff; Derek Cridebring; Ajay Goel
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.